Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Reports on breast cancer findings from University of Texas provide new insights
July 10th, 2008
" Several adjuvant chemotherapy trials suggested that cytotoxic treatment is less effective in patients with estrogen receptor ( ER) - positive breast cancers. The aim of the present study was to assess the efficacy of adjuvant docetaxel and anthracycline therapy according to ER expression in two randomized clinical trials," scientists writing in the Journal of Clinical Oncology report. "Patients and Methods Pooled data from two randomized trials, BCIRG001 and PACS01, were examined. Hazard ratios for recurrence and survival were estimated by Cox proportional hazards models and were adjusted for clinical variables. Interaction between docetaxel and ER expression...
Source: Women's Health Weekly (2008-07-10)
|
